Aardvark Therapeutics (AARD) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Stablecoin Development (SDEV) has outperformed Aardvark Therapeutics (AARD) over the past year, losing 55.9% versus a loss of 71.5%. Stablecoin Development is the larger company by market cap ($110.7 million vs $104.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AARD | SDEV |
|---|---|---|
| Share price | $4.75 | $2.14 |
| Market cap | $103.95M | $110.75M |
| 1-day change | -4.23% | -23.02% |
| YTD return | -62.21% | -90.14% |
| 1-year return | -71.51% | -55.87% |
| 5-year return | — | -99.92% |
| EPS (TTM) | $-3.21 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $99.75 |
| 52-week low | $3.35 | $0.78 |
| Distance from 52-week high | -72.42% | -97.85% |
| Average volume | 209.46K | 11.42M |
| Shares outstanding | 21.88M | 51.75M |
| Employees | — | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SDEV has outperformed AARD by 15.6 percentage points over the past year.
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
AARD vs SDEV FAQ
Which is bigger, Aardvark Therapeutics or Stablecoin Development?
Stablecoin Development (SDEV) is larger, with a market capitalization of $110.75M compared with $103.95M for Aardvark Therapeutics (AARD).
Which stock has performed better over the past year, AARD or SDEV?
SDEV returned -55.87% over the past 12 months, compared with -71.51% for AARD (price return, excluding dividends). Past performance does not predict future results.
Are Aardvark Therapeutics and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.